| 发明名称 |
CRYSTALLINE SALTS OF (S)-4-(3-[N-(2-[4-(5-CARBAMOYL-2-PYRIDYLOXY)PHENYL]-1,1-DIMETHYLETHYL)AMINO]-2-HYDROXYPROPOXY)INDOLE |
| 摘要 |
The present invention relates to crystalline salts of (S)-4-(3-[N-(2-[4-(5-carbamoyl-2-pyridyloxy)phenyl]-1,1-dimethylethyl)amino]-2-hydroxypropoxy)indole, a pharmaceutical formulation containing said salts, a process for preparing said salts, methods for treating obesity and Type II diabetes using said salt and to a method for agonizing the beta 3 receptor using said salts.
|
| 申请公布号 |
WO0136411(A1) |
申请公布日期 |
2001.05.25 |
| 申请号 |
WO2000US28873 |
申请日期 |
2000.11.02 |
| 申请人 |
ELI LILLY AND COMPANY;BUSH, JULIE, KAY;FISHER, JACK, WAYNE |
发明人 |
BUSH, JULIE, KAY;FISHER, JACK, WAYNE |
| 分类号 |
A61K31/4439;A61P3/04;A61P3/10;C07D401/12;(IPC1-7):C07D401/12;A61K31/44 |
主分类号 |
A61K31/4439 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
